PAXLOVID, a new antiviral pill to treat Covid-19, will be rolled out at selected polyclinics and Public Health Preparedness Clinics (PHPCs) in phases to patients to reduce the likelihood of hospitalisation.
This is the first Covid pill approved by the Health Sciences Authority (HSA) for use here. Currently, treatment is based on symptoms such as cough, fever and sore throat.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!